Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
30.16
-1.84 (-5.75%)
Nov 21, 2025, 11:59 AM HKT

HKG:2315 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
132.2133.54-382.95-601.95-545.58-428.09
Depreciation & Amortization
165.62165.98179.3174.1128.143.37
Other Amortization
3.23.23.15---
Loss (Gain) From Sale of Assets
-0.01-0.01-1.830.08-0.391.2
Loss (Gain) From Sale of Investments
0.360.36-0.15-44.7-2.13-6.19
Loss (Gain) on Equity Investments
29.7529.7510.0314.770.4-0.09
Stock-Based Compensation
22.6422.6430.9815.3127.75132.45
Provision & Write-off of Bad Debts
9.49.44.281.423.121.51
Other Operating Activities
153.2977.7889.842.0433.1359.76
Change in Accounts Receivable
-96.68-96.68-39.02-4.59-35.86-32.38
Change in Inventory
-12.93-12.933.79-6.4-29.96-5.29
Change in Accounts Payable
-47.35-47.3511.947.3519.0416.78
Change in Unearned Revenue
30.830.89.98-8.0716.758.49
Change in Income Taxes
----0.8--
Change in Other Net Operating Assets
-5.24-5.244.168.1719.86-16.84
Operating Cash Flow
385.07211.25-76.65-303.27-365.78-225.31
Capital Expenditures
-46.42-37.13-126.62-240.27-198.67-296.42
Sale of Property, Plant & Equipment
1.131.1126.341.644.760.05
Divestitures
----6.86--
Investment in Securities
-142.76-101.09-91.76109.78108.2
Investing Cash Flow
-188.05-137.12-100.28-153.74-84.13-188.18
Long-Term Debt Issued
-239.33319.91209.6--
Long-Term Debt Repaid
--207.38-172.98-68.77-57.13-75.91
Net Debt Issued (Repaid)
-21.8631.94146.93140.83-57.13-75.91
Issuance of Common Stock
---521.06311.04948.36
Repurchase of Common Stock
-19.13-9.51-8.2-18.99--
Other Financing Activities
-124.86-114.46-176.55-55.69-34.47-4.01
Financing Cash Flow
-165.85-92.03-37.82587.2219.44868.44
Foreign Exchange Rate Adjustments
4.042.753.4714.24-0.38-4.04
Net Cash Flow
35.22-15.15-211.28144.44-230.85450.91
Free Cash Flow
338.66174.12-203.26-543.54-564.45-521.73
Free Cash Flow Margin
28.44%17.76%-28.35%-101.81%-159.20%-205.78%
Free Cash Flow Per Share
0.850.44-0.51-1.43-1.56-4.04
Cash Interest Paid
30.9831.2824.08177.664.01
Cash Income Tax Paid
22.289.320.64---
Levered Free Cash Flow
164.89.32-231.5-423.55-397.16-
Unlevered Free Cash Flow
211.5966.62-169.1-388.46-372.52-
Change in Working Capital
-131.39-131.39-9.2495.65-10.18-29.24
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.